Format

Send to

Choose Destination
Nat Rev Endocrinol. 2014 Jun;10(6):315-6. doi: 10.1038/nrendo.2014.41. Epub 2014 Apr 1.

Neuroendocrine cancer. Closing the GAPP on predicting metastases.

Author information

1
Institute of Clinical Chemistry & Laboratory Medicine and Department of Medicine III, University Hospital, Technische Universit├Ąt Dresden, Fetscherstrasse 74, 01307 Dresden, Germany.
2
Department of Pathology, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA.

Abstract

A promising grading system to predict metastasis in patients with phaeochromocytoma and paraganglioma assigns risk according to selected histological and other criteria. Such risk stratification might be useful for personalized management and screening programmes, as it could limit the costs of follow-up and reduce the risk of disseminated disease.

PMID:
24686203
DOI:
10.1038/nrendo.2014.41
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center